WuXi ATU Grand Opening

WuXi ATU Opens New Facility in Philadelphia, Tripling Testing Capacity to Support Global Customers

WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced the official opening of its advanced therapies testing facility at 400 Rouse Boulevard in Philadelphia’s Navy Yard. The new facility, which includes 140,000 square feet laboratories, will further enhance the company’s Contract Testing, Development and Manufacturing Organization (CTDMO) business model by tripling the company’s previous testing capacity, meeting the increasing needs of customers in cell and gene therapy industry.

The new state-of the-art facility is an expansion of WuXi ATU’s existing Navy Yard Campus, which opened in 2020. This addition will strengthen the existing analytical development and testing capacity and capability.

“WuXi ATU has significant expertise in assay development, biologics safety testing, viral clearance and commercial lot release assays, and we are proud to bring that knowledge to our customers,” said Dr. David Chang, Chief Executive Officer of WuXi ATU. “We are committed to enabling these partners to bring ground-breaking therapeutics to patients as quickly, reliably and consistently as possible.”

“WuXi ATU has always been at the forefront of innovation in Philadelphia,” said Kate McNamara, PIDC’s Senior Vice President, Navy Yard. “We are thrilled to celebrate their continued expansion and growth with the opening of the new advanced therapies testing facility at the Navy Yard.”

As a CTDMO with operations globally, WuXi ATU’s unique business model integrates powerful testing capabilities with its advanced therapies’ process development and manufacturing platforms, such as TESSA technology for AAV manufacturing and XLenti stable solutions for lentiviral manufacturing. This allows all assay development, biosafety, viral clearance and product release testing to be completed in-house, shortening customers’ timelines for the approval of advanced therapies. WuXi ATU has supported more than 1,700 customer submissions for biosafety testing through industry-leading testing and analytical assay development experience, enabling the delivery of more effective and accessible advanced therapies to patients.

 

About WuXi Advanced Therapies (WuXi ATU)

As the advanced therapies business unit of WuXi AppTec, WuXi Advanced Therapies is a Contract Testing, Development and Manufacturing Organization (CTDMO) that offers integrated platforms to transform the discovery, development, testing, manufacturing, and commercialization of cell and gene therapies. Our services and solutions accelerate time to market and support customer programs around the world. For more information, please visit www.advancedtherapies.com.

About WuXi AppTec

As a global company with operations across AsiaEurope, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received AA ESG rating from MSCI in 2021 and its open-access platform is enabling more than 5,600 collaborators from over 30 countries to improve the health of those in need – and to realize the vision that “every drug can be made and every disease can be treated.” Please visit: http://www.wuxiapptec.com

Media Contact:
Davy Wu
mediainquiries@wuxiapptec.com

Customer Contact:
Min Park
+1 (215) 218-5500
atu.info@wuxiapptec.com

PIDC welcomes the Dominion Energy team on Nov 1!

Navy Yard Electric Utility Transitions Operations to Dominion Energy

Today Dominion Energy takes over the 10-year electric utility Operations and Maintenance (O&M) services contract for the Navy Yard. This contract was the culmination of a lengthy, highly competitive solicitation process announced in May 2021. Dominion Energy will provide responsive on-site management to the Navy Yard and its customers, who will gain industry-leading service reliability, financial performance, innovation, responsiveness, and service reliability to support effective response to routine, urgent, and emergency service needs and interruptions.

PIDC welcomes the Dominion Energy team on Nov 1!

The Dominion team will provide excellent service to existing and future Navy Yard businesses and customers, and will allow for the next phase of real estate development to grow and flourish.  Meet the two on-site team members and say hello if you see them around campus!

Jeremy Rigau, Dominion Energy, Manager Base Privatization

Name: Jeremy Rigau
Title: Manager, Base Privatization
Years at Dominion Energy: 13 years
One thing they are most looking forward to at the Navy Yard: Jeremy can’t wait to bring his family to the Navy Yard to see a movie at the PFS Drive-in. As a Philadelphia transplant, he is looking forward to taking his family to see and experience all the history and culture that Philadelphia has to offer.

Michael “MJ” Jones, Dominion Energy, Base Design Project Coordinator

Name: Michael ‘MJ’ Jones
Title: Base Design Project Coordinator
Years at Dominion Energy: 16 years
One thing they are most looking forward to at the Navy Yard: Going to a Sixers game after work!

Since the announcement, Dominion’s team has worked closely with the operations team from DTE on a comprehensive transition to ensure a seamless handoff today. PIDC and the Navy Yard team are grateful to DTE for many years of excellent service and assistance during the transition period.

Since the military base closed and was transferred to PIDC’s leadership in 2000, the Navy Yard’s electric utility system has grown to accommodate more customers and has become more sophisticated. It is a large, independently operated unregulated energy grid, and since 2010, more than $35 million in upgrades have been performed and new capacity added, including the addition of a peaking plant, a battery storage plant, and Pennsylvania’s first community solar project.

The Navy Yard continues to grow as a premiere location for businesses and employees in Philadelphia. The next phase of development will solidify the Navy Yard’s place as a leader in business, manufacturing, R&D, and life sciences and will include the creation of a vibrant mixed-use district including retail, makerspace, and – for the first time since the base closure – residential development. With this next phase of commercial and residential development, the Navy Yard is expected to add an additional 5.4 million square feet of space at full build-out over the next 15 to 20 years and plans to grow from its peak demand of 33 megawatts serving 105 accounts and 120 facilities to 55 megawatts. Additionally, Dominion Energy will also ensure future energy needs are met as new capacity is added to the private grid.

Dominion Energy offers comprehensive O&M and business management expertise backed by 100+ years’ experience as one of the nation’s largest regulated utility companies, serving more than 3.2 million electric customers in North Carolina, South Carolina, and Virginia. Dominion Energy also extends 15 years of experience in owning, operating, and maintaining privatized, non-regulated systems on critical installations (similar to the Navy Yard) in South Carolina, Texas, Virginia, and Washington, D.C.